STOCK TITAN

[6-K] Ascentage Pharma Group International Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary
Riscrivi il testo seguente:
Reescribe el siguiente texto:
다음 텍스트를 다시 작성하세요:
Réécrivez le texte suivant :
Schreiben Sie den folgenden Text um:
Positive
  • None.
Negative
  • None.
Riscrivi il testo seguente:
Reescribe el siguiente texto:
다음 텍스트를 다시 작성하세요:
Réécrivez le texte suivant :
Schreiben Sie den folgenden Text um:

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

For the month of July 2025

 

Commission File Number: 001-42484

 

ASCENTAGE PHARMA GROUP INTERNATIONAL

(Translation of Registrant’s name into English)

 

68 Xinqing Road

Suzhou Industrial Park

Suzhou, Jiangsu

China

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒            Form 40-F ☐

 

 

 

 

 

On July 25, 2025, Ascentage Pharma Group International issued an announcement entitled, “Closing of Placing of Existing Shares and Top-Up Subscription of New Shares Under General Mandate”. A copy of the announcement is furnished as Exhibit 99.1 to this Report.

 

1

 

 

INDEX TO EXHIBITS

 

Exhibit
Number
 
  Exhibit Title
99.1  

Announcement dated July 25, 2025

 

2

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

  

  ASCENTAGE PHARMA GROUP INTERNATIONAL
     
Date: July 25, 2025 /s/ Dajun Yang
  Name: Dajun Yang
  Title: Chief Executive Officer

 

3

  

Ascentage Pharma Group International

NASDAQ:AAPG

AAPG Rankings

AAPG Latest News

AAPG Latest SEC Filings

AAPG Stock Data

3.55B
7.33M
0.16%
Biotechnology
Healthcare
Link
China
Suzhou